Table 2 Characteristics of patients with cervical adenocarcinoma.
Number of patients | n = 82 |
|---|---|
Age (years), median (range) | 50.4 (30–85) |
FIGO stage n, (%) | |
IA | 5 (6.1) |
IB | 48 (58.5) |
IIA | 5 (6.1) |
IIB | 14 (17.1) |
IIIA | 0 |
IIIB | 8 (9.8) |
IVA | 0 |
IVB | 2 (2.4) |
Tumor size (cm) median (range) | 32.7 (0–80) |
Unknown | 5 |
Tumor size | |
< 4 cm | 49 (59.6) |
≥ 4 cm | 33 (40.4) |
LVSI | |
Yes | 39 (47.6) |
No | 29 (35.4) |
Unknown | 14 (17.0) |
Metastases pelvic LN | |
Yes | 17 (20.7) |
No | 65 (79.3) |
Metastases paraaortic LN | |
Yes | 3 (3.7) |
No | 79 (92.3) |
Metastases distance | |
Yes | 1(1.2) |
No | 81 (98.8) |
Treatment | |
Surgery | 38 (46.3) |
Surgery + adjuvant (RT or CCRT or CT) | 40 (48.8) |
Radiotherapy (RT or CCRT) | 4 (4.8) |
Chemotherapy | 0 |
Recurrence within 5 years | |
Yes | 20 (24.4) |
No | 60 (75.6) |
Death within 5 years | |
Yes | 19 (23.2) |
No | 63 (76.8) |
